A team of Singaporean researchers has identified a mechanism where mosquito saliva can help boost the human body's immune response during chikungunya virus (CHIKV) infection. 

The research, published in Nature Communications, showed that sialokinin -- a bioactive peptide in Aedes mosquito saliva -- binds to neurokinin receptors on immune cells and suppresses monocyte activation.